Neoleukin Therapeutics, Inc.

NLTXNASDAQHealthcare

$3.49

+$0.05(+1.45%)

Market Cap$8199685

P/E Ratio—

52W High$18.8

52W Low$3.42

Avg Volume6K

Open$3.45

Beta1.10

Employees Ownership Insider Trades

Neoleukin Therapeutics, Inc. (NLTX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · NLTX · as of Mar 24, 2026

Latest filing snapshot

131

+24+22.43%vs prior year

Neoleukin Therapeutics, Inc. (NLTX) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

131

Change (1Y)

+24

Growth % (1Y)

+22.43%

Revenue / Employee

—

Net Income / Employee

$-689.7K

Market Cap

$8M

NLTX Employee Count

2014 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-24	2025-12-31	131	+24	+22.43%
2025-03-24	2024-12-31	107	+51	+91.07%
2023-03-20	2022-12-31	56	-35	-38.46%
2022-03-01	2021-12-31	91	+21	+30.00%
2021-03-25	2020-12-31	70	+34	+94.44%
2020-03-12	2019-12-31	36	+28	+350.00%
2019-03-07	2018-12-31	8	-43	-84.31%
2018-03-12	2017-12-31	51	+13	+34.21%
2017-03-09	2016-12-31	38	+14	+58.33%
2016-03-14	2015-12-31	24	+0	+0.00%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Drug Manufacturers - Specialty & Generic

#SymbolCompanyEmployeesMkt Cap

LCI

Lannett Company, Inc.

Neoleukin Therapeutics, Inc.YOU

131$8M #4

BIOR

Biora Therapeutics, Inc.

58$1M

CSCI

COSCIENS Biopharma Inc.

40$9M

DMKPQ

DMK Pharmaceuticals Corporation

11$0M #7

CHRO

Channel Therapeutics Corporation

4$9M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · NLTX peer comparison

About NLTX employees

NLTX Employees · Headcount

Neoleukin Therapeutics, Inc. (NLTX) employee data is sourced from the annual SEC 10-K filing. As of 2025, Neoleukin Therapeutics, Inc. had 131 full-time employees globally. Full-time employees only. Global consolidated headcount.

Neoleukin Therapeutics, Inc.'s workforce increased by 24 (22.43%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

NLTX Employees · 5 questions

As of the latest SEC 10-K filing (2025), Neoleukin Therapeutics, Inc. had 131 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Neoleukin Therapeutics, Inc. employee counthow many employees does Neoleukin Therapeutics, Inc. haveNLTX total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-24